Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedAdded the MeSH term 'Clear cell carcinoma of kidney' and a 'Genetic and Rare Diseases Information Center' resource reference under Resources.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2 label.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added and the previous government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check61 days agoChange DetectedThe page now includes a site-wide notice about government funding and NIH operations, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a Show glossary feature and updated the page revision to v3.4.0; capitalization tweaks were made to QC criteria wording and FEAR Act data, replacing the previous v3.3.4 text.SummaryDifference0.2%

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.